Taiwan FDA registration ce24e3057b28120ed10707cb62553ece

The Binding Site Optilite Rheumatoid Factor Kit

TW: 邦迪斯歐普羅類風濕性因子分析套組

Taiwan·Risk Class 2·MD·THE BINDING SITE GROUP LTD·Registered Sep 25, 2018 – Sep 25, 2028Active

Registration details

Analysis ID: ce24e3057b28120ed10707cb62553ece
License Form: Ministry of Health Medical Device Import No. 031480
Customs Code: DHA05603148003

Company information

Manufacturer: THE BINDING SITE GROUP LTD
Manufacturer Country: United Kingdom
Authorized Representative: EVERLIGHT BIOTECH(TAIWAN) CO., LTD.

Product details

Intended Use: This product is used with the Binding Site Plite analyzer to quantify rheumatoid factors in serum in vitro.
Product Type (Level 1): C Immunology and microbiology devices
Product Type (Level 2): C5775 Rheumatoid factor immunoassay system
Import Information: Imported from abroad

Dates and status

Registration Date: Sep 25, 2018
Expiry Date: Sep 25, 2028

About this record

Access comprehensive regulatory information for The Binding Site Optilite Rheumatoid Factor Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ce24e3057b28120ed10707cb62553ece and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.